Fight Aging! is a publication dedicated to the eradication of age-related diseases through the advancement of modern medicine and control of aging mechanisms. Thousands of subscribers receive our weekly newsletter, which provides updates and opinions on this important goal.
For those interested in the longevity industry, founder Reason offers consulting services to investors, entrepreneurs, and others. To learn more about these services, visit our website.
Additionally, our recent newsletter covers a study on epigenetic age following senolytic treatment in humans. While the treatment showed short-term effects, there are questions surrounding its lasting impact on aging. Another study explores the effects of senolytic drugs, such as Dasatinib, Quercetin, and Fisetin, on DNA methylation clocks and epigenetic age.
Moreover, a study on mitochondrial oxidative stress and cellular senescence in old mice challenges existing beliefs on aging. Despite efforts to reduce mitochondrial oxidative stress through catalase upregulation, the burden of cellular senescence remained unchanged.
For more information on these topics, visit our website and subscribe to our newsletter for regular updates. Together, we strive to combat age-related diseases and extend healthy lifespan.
